SLC29A1 Produits
(Solute Carrier Family 29 (Nucleoside Transporters), Member 1 (SLC29A1))
Catégories
This gene is a member of the equilibrative nucleoside transporter family. The gene encodes a transmembrane glycoprotein that localizes to the plasma and mitochondrial membranes and mediates the cellular uptake of nucleosides from the surrounding medium. The protein is categorized as an equilibrative (as opposed to concentrative) transporter that is sensitive to inhibition by nitrobenzylthioinosine (NBMPR). Nucleoside transporters are required for nucleotide synthesis in cells that lack de novo nucleoside synthesis pathways, and are also necessary for the uptake of cytotoxic nucleosides used for cancer and viral chemotherapies. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories SLC29A1 en vedette
SLC29A1 Anticorps
High quality antibodies with extensive validation data.
SLC29A1 Kits ELISA
Reliable ELISA kits for a wide range of species.
SLC29A1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
SLC29A1 recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Mouse
Application
WB, IHC (p), FACS
Validations
- (3)
- (5)
N° du produit
ABIN387940
Quantité
400 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC, IF
Validations
- (3)
N° du produit
ABIN7151966
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human, Mouse
Application
WB
Validations
- (2)
- (2)
N° du produit
ABIN387941
Quantité
200 μL
Fiche technique
Fiche technique
SLC29A1 recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6970331
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Mouse
Analytical Method
Validations
N° du produit
ABIN1132220
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Rat
Analytical Method
Validations
N° du produit
ABIN1132221
Quantité
96 tests
Fiche technique
Fiche technique
SLC29A1 recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
- (1)
N° du produit
ABIN1778128
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (1)
N° du produit
ABIN2732169
Quantité
20 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits SLC29A1
: "Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine." dans: Nature, (2022) (PubMed).: "In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer ..." dans: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, (2017) (PubMed).
: "Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5." dans: Oncotarget, Vol. 8, Issue 7, pp. 11748-11762, (2017) (PubMed).
: "SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia." dans: Cancer chemotherapy and pharmacology, Vol. 78, Issue 3, pp. 533-40, (2016) (PubMed).
: "Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated ..." dans: British journal of cancer, Vol. 111, Issue 7, pp. 1275-84, (2014) (PubMed).
: "Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. ..." dans: Journal of the National Cancer Institute, Vol. 106, Issue 1, pp. djt347, (2014) (PubMed).
: "Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in ..." dans: Surgery, Vol. 153, Issue 4, pp. 565-75, (2013) (PubMed).
: "Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine ..." dans: Annals of surgical oncology, Vol. 19 Suppl 3, pp. S646-55, (2012) (PubMed).
: "Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. ..." dans: The Journal of clinical investigation, Vol. 122, Issue 2, pp. 693-710, (2012) (PubMed).
: "Host-based ribavirin resistance influences hepatitis C virus replication and treatment response." dans: Journal of virology, Vol. 85, Issue 14, pp. 7273-83, (2011) (PubMed).
Synonymes et noms alternatifs relatifs à SLC29A1
solute carrier family 29 member 1 (Augustine blood group) (SLC29A1), solute carrier family 29 member 1 (Slc29a1), solute carrier family 29 (nucleoside transporters), member 1 (Slc29a1), 1200014D21Rik, AA407560, ENT1, rENT1Protein level used designations for SLC29A1
- equilibrative NBMPR-sensitive nucleoside transporter
- equilibrative nitrobenzylmercaptopurine riboside (NBMPR)-sensitive nucleoside transporter
- equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter
- equilibrative nucleoside transporter 1
- nucleoside transporter, es-type
- solute carrier family 29 (nucleoside transporters), member 1
- solute carrier family 29 member 1
- solute carrier family 29, member 1
- NBMPR-sensitive equilibrative nucleoside transporter
- equilibrative nucleoside transporter 1 variant delta 11
Vous êtes ici:
